Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

被引:204
作者
Mendoza, FA
Artlett, CM
Sandorfi, N
Latinis, K
Piera-Velazquez, S
Jimenez, SA
机构
[1] Thomas Jefferson Univ, Div Rheumatol, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[2] Temple Univ, Dept Med, Philadelphia, PA 19122 USA
[3] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[4] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Jefferson Med Coll, Philadelphia, PA 19107 USA
关键词
nephrogenic fibrosing dermopathy; scleroderma; fibrosis; TGF beta;
D O I
10.1016/j.semarthrit.2005.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To review the clinical and laboratory features of 12 cases of nephrogenic fibrosing dermopathy (NFD) studied at our institution and of 70 previously described cases in the literature. METHODS Clinical evaluation and laboratory studies of 12 patients with NFD associated with chronic hemodialysis or peritoneal dialysis for end-stage renal disease and a review of 23 previous publications describing 70 patients with this disease. RESULTS Eleven patients undergoing chronic hemodialysis and 1 patient undergoing chronic peritoneal dialysis for end-stage renal failure developed a severe and progressive cutaneous fibrotic process with woody induration of legs, thighs, hands, and forearms, and severe loss of motion and flexion contractures in multiple joints. Several patients displayed systemic involvement including fibrosis of muscles, myocardium, and lungs and marked elevations of the erythrocyte sedimentation rate and/or C-reactive protein. Three patients died within 2 years of symptom onset. A review of previously published reports of this disorder confirmed the presence of systemic involvement and a poor prognosis with a high mortality rate. CONCLUSIONS NFD is a severe and usually progressive systemic fibrotic disease affecting the dermis, subcutaneous fascia, and striated muscles. It also appears that the disease can cause fibrosis of lungs, myocardium, and other organs.
引用
收藏
页码:238 / 249
页数:12
相关论文
共 29 条
[1]   Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis [J].
Baron, PW ;
Cantos, K ;
Hillebrand, DJ ;
Hu, KQ ;
Ojogho, ON ;
Nehlsen-Cannarella, S ;
Concepcion, W .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2003, 25 (03) :204-209
[2]  
Chiu Henry, 2004, Liver Transpl, V10, P465, DOI 10.1002/lt.20068
[3]   Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin [J].
Chung, HJ ;
Chung, KY .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (03) :596-597
[4]   Nephrogenic fibrosing dermopathy [J].
Cowper, SE ;
Su, LD ;
Bhawan, J ;
Robin, HS ;
LeBoit, PE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2001, 23 (05) :383-393
[5]   Scleromyxoedema-like cutaneous diseases in renal-dialysis patients [J].
Cowper, SE ;
Robin, HS ;
Steinberg, SM ;
Su, LD ;
Gupta, S ;
LeBoit, PE .
LANCET, 2000, 356 (9234) :1000-1001
[6]   Nephrogenic fibrosing dermopathy: the first 6 years [J].
Cowper, SE .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (06) :785-790
[7]   Scleromyxoedema-like eruption following haemodialysis or nephrogenic fibrosing dermopathy? [J].
Dawn, G ;
Holmes, SC .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (01) :167-168
[8]   Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy [J].
Edsall, LC ;
English, JC ;
Patterson, JW .
JOURNAL OF CUTANEOUS PATHOLOGY, 2004, 31 (03) :247-253
[9]  
Engelen J W, 2003, Ned Tijdschr Geneeskd, V147, P2435
[10]   Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure [J].
Evenepoel, P ;
Zeegers, M ;
Segaert, S ;
Claes, K ;
Kuypers, D ;
Maes, B ;
Flamen, P ;
Fransis, S ;
Vanrenterghem, Y .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (02) :469-473